Correlation of thyroid hormone, retinoid X, peroxisome proliferator‑activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma

Ditsch,Nina; Mayr,Doris; Lenhard,Miriam; Strauss,Carolin; Vodermaier,Andrea; Gallwas,Julia; Stoeckl,Doris; Graeser,Monika; Weissenbacher,Tobias; Friese,Klaus; Jeschke,Udo

doi:10.3892/ol.2012.799

Correlation of thyroid hormone, retinoid X, peroxisome proliferator‑activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma

Authors:
- Nina Ditsch
- Doris Mayr
- Miriam Lenhard
- Carolin Strauss
- Andrea Vodermaier
- Julia Gallwas
- Doris Stoeckl
- Monika Graeser
- Tobias Weissenbacher
- Klaus Friese
- Udo Jeschke
View Affiliations

Affiliations: Department of Obstetrics and Gynaecology, Grosshadern, Ludwig‑Maximilians‑University, Munich, D-81377, Germany , Department of Pathology, Ludwig‑Maximilians‑University, Munich, D-80337, Germany , Department of Obstetrics and Gynaecology, Christian‑Albrechts‑University of Kiel, Kiel, D-24105, Germany, Department of Psychology, University of British Columbia, Vancouver, BC, Canada, Department of Obstetrics and Gynaecology, University of Cologne, Cologne, D-50931, Germany, Department of Obstetrics and Gynaecology, Maistrasse, Ludwig‑Maximilians‑University, Munich, D-80337, Germany
Published online on: July 13, 2012 https://doi.org/10.3892/ol.2012.799
Pages: 665-671

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑steroidal nuclear receptors play a major role in breast cancer development. A correlation among, and possible prognostic function of, the members of the nuclear receptor superfamily has been discussed controversially over the years. Hence, we conducted a quantification of the different expression levels of the thyroid receptor (TR), retinoid X receptor (RXR), peroxisome proliferator‑activated receptor (PPAR) and vitamin D receptor (VDR) in malignant breast tumour tissue samples. Patients diagnosed and treated for breast cancer between 1990 and 2000 were included. Receptor expression was detected by immunohistochemical staining. Correlation analyses for the expression of the receptors were performed for the clinical and histopathological data. The paraffin‑embedded tissue from 82 breast cancer patients was available. The different steroid receptors showed varying results when correlated with known histopathological markers. TRα2 demonstrated the most significant correlations with steroid hormone receptors. Significant correlations between the major isoforms of TR, and between RXR, PPAR and VDR, were demonstrated in the patient sample. The immunohistochemical association of these receptors may provide the first proof of an interaction on the molecular level. This assumption awaits confirmation in studies with larger cohorts.

View Figures

View References

1.	H EscrivaS BertrandV LaudetThe evolution of the nuclear receptor superfamilyEssays Biochem4011262004
2.	M SchräderS NayeriJP KahlenKM MüllerC CarlbergNatural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivationMol Cell Biol15115411611995
3.	JH SegarsMS MarksS HirschfeldPH DriggersE MartinezJF GrippoW WahliK OzatoInhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathwaysMol Cell Biol42258226819938384307
4.	T TanakaBL DanchekLC TrifilettiRE BirnkrantBJ TaylorSH GarfieldU ThorgeirssonLM De LucaAltered localization of retinoid X receptor α coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cellsMol Cell Biol24397239822004
5.	P TontonozE HuBM SpiegelmanStimulation of adipogenesis in fibroplasts by PPARγ2, a lipid-activated transcription factorCell79114711561994
6.	RC SmallridgeKR LathamNuclear thyroid hormone receptor in human breast tumoursClin Res284211980
7.	M FriedrichR Axt-FliednerC Villena-HeinsenW TilgenW SchmidtJ ReichrathAnalysis of vitamin D-receptor (VDR) and retionoid X-receptor α in breast cancerHistochem J3435402002
8.	I CondeMVT LoboJ ZamoraJ PérezFJ GonzálezE AlbaB FraileR PaniaguaMI ArenasHuman pregnane X receptor is espressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-αBMC Cancer8174200818565212
9.	J LiQ LinHG YoonZQ HuangBD StrahlCD AllisJ WongInvolvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptorMol Cell Biol2256885697200210.1128/MCB.22.16.5688-5697.200212138181
10.	J Carlstedt-DukePE StrömstedtB PerssonE CederlundJA GustafssonH JörnvallIdentification of hormone-interacting amino acid residues within the steroid-binding domain of the glucocorticoid receptor in relation to other steroid hormone receptorsJ Biol Chem263684268461988
11.	J Carlstedt-DukeCellular estrogen activity: implications for pulsed estrogen therapyMaturitas38Suppl 1S7S13200110.1016/S0378-5122(01)00199-211390119
12.	Y LingX XuJ HaoX LingX DuX LiuX ZhaoAberrant methylation of the TRB gene in tissue and plasma of breast cancer patientsCancer Genet Cytogenet196140145201010.1016/j.cancergencyto.2009.09.01020082849
13.	E MuellerP SarrafP TontonozRM EvansKJ MartinM ZhangC FletcherS SingerBM SpiegelmanTerminal differentiation of human breast cancer through PPARγMol Cell14654701998
14.	N SuhY WangCR WilliamsR RisingsongT GilmerTM WillsonMB SpornA new ligand for the peroxisome proliferator activated receptor gamma (PPARgamma), GW7845, inhibits rat mammary carcinogenesisCancer Res5956715673199910582681
15.	E ElstnerEA WilliamsonC ZangJ FritzD HeberM FennerK PossingerHP KoefflerNovel therapeutic approach: ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cellsBreast Cancer Res Treat741551652002
16.	MW KilgorePL TateS RaiE SengokuTM PriceMCF-7 and T47 D human breast cancer cells contain a functional peroxisomal responseMol Cell Endocrinol129229235199710.1016/S0303-7207(97)04057-49202406
17.	GM ZinserJE WelshAccelerated mammary gland development during pregnancy and delayed post-lactational involution in vitamin D3 receptor null miceMol Endocrinol1822082223200410.1210/me.2003-046915178742
18.	AF GombartQT LuongHP KoefflerVitamin D compounds: activity against microbes and cancerAnticancer Res264A25312542200616886661
19.	D DianW JanniC KuhnD MayrU KarstenI MylonasK FrieseU JeschkeEvaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodiesOnkologie32238244200910.1159/000209280
20.	A FritzC PercyA JackK ShanmugaratnamL SobinDM ParkinS WhelanInternational Classification of Diseases for Oncology3rd editionWorld Health OrganizationGeneva2000
21.	EW ElstonIO EllisMethod for grading breast cancerJ Clin Pathol46189190199310.1136/jcp.46.2.189-b8459046
22.	W RemmeleHE StegnerRecommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissuePathologe81381401987(In German)
23.	U JeschkeA BischofR SpeerDevelopment of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumoursAnticancer Res25158115892005
24.	I MylonasJ MakovitzkyU JeschkeV BrieseK FrieseB GerberExpression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma in situ (DCIS) versus invasive breast cancer aloneAnticancer Res2517191723200516033090
25.	WA KnightRB LivingstonEJ GregoryWL McGuireEstrogen receptor as an independent prognostic factor for early recurrence in breast cancerCancer Res37466946711977922747
26.	CK OsborneWL McGuireThe use of steroid hormone receptors in the treatment of human breast cancer: a reviewBull Cancer662032101979385079
27.	PPA SmythThe thyroid and breast cancer: a significant association?Ann Med29189191199710.3109/078538997089993359240623
28.	N DitschS LiebhardtF von KochM LenhardM VogeserC SpitzwegJ GallwasB TothThyroid function in breast cancer patientsAnticancer Res3017131717201020592366
29.	M LemaireL Baugnet-MahieuNuclear thyroid hormone receptors in human cancer tissuesAnticancer Res669570019863019222
30.	JM SilvaG DomínguezJM González-SanchoJM GarcíaJ SilvaC García-AndradeA NavarroA MuñozF BonillaExpression of thyroid hormone receptor/erbA genes is altered in human breast cancerOncogene2143074316200210.1038/sj.onc.120553412082618
31.	K WuY ZhangXC XuJ HillJ CelestinoHT KimThe retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumours in transgenic miceCancer Res6263766380200212438218
32.	HP KoefflerPeroxisome proliferator-activated receptor gamma and cancersClin Cancer Res919200312538445
33.	D BonofiglioE CioneH QiA PingitoreM PerriS CatalanoD VizzaML PannoG GenchiSA FuquaS AndoCombined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptic pathway in human breast cancer cellsAm J Pathol17512701280200910.2353/ajpath.2009.08107819644018
34.	T SuzukiS HayashiY MikiY NakamuraT MoriyaA SugawaraT IshidaN OhuchiH SasanoPeroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actionsEndocr Relat Cancer13233250200610.1677/erc.1.0107516601291
35.	N DitschT VrekoussisM LenhardI RühlJ GallwasT WeissenbacherK FrieseD MayrA MakrigiannakisU JeschkeRetinoid X receptor alpha (RXRα) and peroxisome proliferator-activated recptor gamma (PPARγ) expression in breast cancer: an immunohistochemical studyIn vivo2687922012
36.	U BergerRA McClellandP WilsonGL GreeneMR HausslerJW PikeK ColstonD EastonRC CoombesImmunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosisCancer Res512392441991
37.	HC FreakeG AbeyasekeraJ IwasakiC MarcocciI MacIntyreRA McClellandRA SkiltonDF EastonRC CoombesMeasurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indicesCancer Res441677168119846322984
38.	BH MasonIM HoldawayPR MullinsLH YeeRG KayProgesterone and estrogen receptors as prognostic variables in breast cancerCancer Res432985299019836850609
39.	JM HowatM HarrisR SwindellDM BarnesThe effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breastBr J Cancer51263270198510.1038/bjc.1985.383966982
40.	ML McCulloughRM BostickTL MayoVitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancerAnnu Rev Nutr29111132200910.1146/annurev-nutr-080508-14124819400699
41.	U BergerP WilsonRA McClellandK ColstonMR HausslerJW PikeRC CoombesImmunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancerCancer Res476793679919872824042
42.	N DitschB TothD MayrM LenhardJ GallwasT WeissenbacherC DanneckerK FrieseU JeschkeThe association between vitamin D receptor and prolonged overall survival in breast cancerJ Histochem Cytochem60121129201210.1369/002215541142915522108646
43.	R Sanchez-MartinezA ZambranoAI CastilloA ArandaVitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimersMol Cell Biol2838173829200710.1128/MCB.01909-0718362166